These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32955256)

  • 1. Discovery of a New Donepezil-like Acetylcholinesterase Inhibitor for Targeting Alzheimer's Disease: Computational Studies with Biological Validation.
    Akhoon BA; Choudhary S; Tiwari H; Kumar A; Barik MR; Rathor L; Pandey R; Nargotra A
    J Chem Inf Model; 2020 Oct; 60(10):4717-4729. PubMed ID: 32955256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease.
    Zueva I; Dias J; Lushchekina S; Semenov V; Mukhamedyarov M; Pashirova T; Babaev V; Nachon F; Petrova N; Nurullin L; Zakharova L; Ilyin V; Masson P; Petrov K
    Neuropharmacology; 2019 Sep; 155():131-141. PubMed ID: 31132435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
    Darreh-Shori T; Hosseini SM; Nordberg A
    J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine.
    Jiang X; Liu C; Zou M; Xie H; Lin T; Lyu W; Xu J; Li Y; Feng F; Sun H; Liu W
    Eur J Med Chem; 2021 Nov; 223():113663. PubMed ID: 34198150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil Inhibits Acetylcholinesterase via Multiple Binding Modes at Room Temperature.
    Silva MA; Kiametis AS; Treptow W
    J Chem Inf Model; 2020 Jul; 60(7):3463-3471. PubMed ID: 32096991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Wang ZM; Cai P; Liu QH; Xu DQ; Yang XL; Wu JJ; Kong LY; Wang XB
    Eur J Med Chem; 2016 Nov; 123():282-297. PubMed ID: 27484514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
    Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
    Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease.
    Castro A; Martinez A
    Mini Rev Med Chem; 2001 Sep; 1(3):267-72. PubMed ID: 12369973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer's disease by donepezil: a metadynamics simulation study.
    Ghosh S; Jana K; Ganguly B
    Phys Chem Chem Phys; 2019 Jul; 21(25):13578-13589. PubMed ID: 31173012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of donepezil administration on acetylcholinesterase activity and altered redox homeostasis in Alzheimer's disease.
    Atukeren P; Cengiz M; Yavuzer H; Gelisgen R; Altunoglu E; Oner S; Erdenen F; Yuceakın D; Derici H; Cakatay U; Uzun H
    Biomed Pharmacother; 2017 Jun; 90():786-795. PubMed ID: 28427041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease.
    Mezeiova E; Chalupova K; Nepovimova E; Gorecki L; Prchal L; Malinak D; Kuca K; Soukup O; Korabecny J
    Curr Alzheimer Res; 2019; 16(9):772-800. PubMed ID: 30819078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposing novel natural compounds against Alzheimer's disease targeting acetylcholinesterase.
    Girgin M; Isik S; Kantarci-Carsibasi N
    PLoS One; 2023; 18(4):e0284994. PubMed ID: 37104478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
    Son M; Park C; Rampogu S; Zeb A; Lee KW
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.
    Gabr MT; Abdel-Raziq MS
    Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
    Kaasinen V; Någren K; Järvenpää T; Roivainen A; Yu M; Oikonen V; Kurki T; Rinne JO
    J Clin Psychopharmacol; 2002 Dec; 22(6):615-20. PubMed ID: 12454562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Donepezil-Arylsulfonamide Hybrids as Multitarget-Directed Ligands for Potential Treatment of Alzheimer's Disease.
    Queda F; Calò S; Gwizdala K; Magalhães JD; Cardoso SM; Chaves S; Piemontese L; Santos MA
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33809771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acetylcholinesterase (AChE) inhibitor and anti-Alzheimer drug donepezil interacts with human erythrocytes.
    Zambrano P; Suwalsky M; Jemiola-Rzeminska M; Strzalka K; Sepúlveda B; Gallardo MJ; Aguilar LF
    Biochim Biophys Acta Biomembr; 2019 Jun; 1861(6):1078-1085. PubMed ID: 30904408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
    Guo Y; Yang H; Huang Z; Tian S; Li Q; Du C; Chen T; Liu Y; Sun H; Liu Z
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31979317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.